OCT 18, 2016 12:30 PM PDT

Tools for the Interrogation of LRRK2 in Parkinson's Disease

Speakers

Abstract:
The study of target-focused, disease relevant biology for drug discovery requires a comprehensive suite of tools that allow multiple aspects of the biology to be assessed.  Thermo Fisher Scientific has pioneered the development of such tools to study the role of the kinase LRRK2 in Parkinson’s Disease, from the first commercial production of full-length protein to enable biochemical assays, to tools that allow the generation and interrogation of dopaminergic neurons harboring disease-specific mutations.  This presentation will focus on how such tools can be used to better understand the disease, and accelerate the drug discovery process.
 

Show Resources
You May Also Like
JUN 05, 2019 05:00 PM CEST
C.E. CREDITS
JUN 05, 2019 05:00 PM CEST
DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
AUG 27, 2019 09:00 AM PDT
C.E. CREDITS
AUG 27, 2019 09:00 AM PDT
DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
JUN 19, 2019 10:00 AM PDT
JUN 19, 2019 10:00 AM PDT
DATE: June 19, 2019TIME: 10:00am PDT, 1:00pm EDT As we develop new methods to create more biologically relevant models for research in understanding disease etiology and in...
NOV 18, 2019 07:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
NOV 18, 2019 07:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
DATE: November 18, 2019TIME: 7:00am PST, 11:00am EST, 4:00pm CEWT How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop th...
MAY 16, 2019 04:00 PM CEST
C.E. CREDITS
MAY 16, 2019 04:00 PM CEST
DATE: May 16, 2019TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST The emergence of NGS is revolutionizing the microbiological sciences and transforming medicine. Deep sequencing has...
MAY 21, 2019 07:00 AM PDT
C.E. CREDITS
MAY 21, 2019 07:00 AM PDT
DATE: May 21, 2019TIMEL 7:00am PT, 10:00am ET Human T cells are central effectors of immunity and cancer immunotherapy. CRISPR-based functional studies in T cells could prioriti...
Loading Comments...
Show Resources